top of page
Search
Posts Coming Soon
Explore other categories in this blog or check back later.
Preliminary safety and clinical activity of ASP3082, a first-in-class, KRAS G12D selective protein degrader in adults with advanced pancreatic, colorectal and non-small cell lung cancer
ESMO24 abstract 608O - Preliminary safety and clinical activity of ASP3082, a first-in-class, KRAS G12D selective protein degrader in...
KICKING KRAS LUNG CANCER!
Upstage Lung Cancer heard the power of hope to kick cancer from Terri Conneran
SPARK study: Studying Pathways of Resistance in KRAS-driven Cancers
Brief Summary “Up to 250 patients from anywhere in the United States can remotely consent and participate to have plasma drawn locally...
bottom of page